Vaccination PromotionNCT05093452
MOTIVAC-MATER-Confiance
A study testing Motivational Interviewing and Information flyer in people with Vaccination Promotion, run by Observatoire Regional de la Sante Provence-Alpes-Côte d'Azur at 2 sites in France.
Trial summary
CONTEXT Vaccination has reduced mortality and morbidity by controlling many vaccine-preventable diseases. To prevent recurrence of these diseases, high vaccine coverages (VCs) (≥ 95%) are needed. But VCs for infants remain suboptimal, and four out of 10 parents doubt the safety and efficacy of vaccines in France. Read more about this study
- Who is it for?
- Ages 18 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Vaccination Promotion
- What is being tested?
- Motivational Interviewing and Information flyer
- Type of treatment
- Vaccines, Pill or oral medicine, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 736 participants
- Where
- 2 sitesFrance
- Study dates
- 8 Nov 2021to 9 Dec 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Mothers aged 18 years or more
- Mothers residing in the PACA region (Provence-Alpes-Côtes-d'Azur) at the time of the delivery
- Mothers who can read and speak French
- Mothers able to give a free and informed consent
- Mothers who provide written consent
Who cannot join
- Mothers of new-born needing to be transferred in a 3rd level maternity ward (because of severe condition)
- Mothers who will leave early maternity ward (<24h)
Trial locations and contacts
2 sites in 1 country.
France2 sites
Hôpital Saint-Joseph
Marseille, 13008
Hôpital Sainte-Musse
Toulon, 83100
About this study
Official title: Motivational Interviewing of Parents in Maternity Wards About Vaccination (Entretien Motivationnel Sur la Vaccination auprès Des Parents Dans Les maternités)
CONTEXT Vaccination has reduced mortality and morbidity by controlling many vaccine-preventable diseases. To prevent recurrence of these diseases, high vaccine coverages (VCs) (≥ 95%) are needed. But VCs for infants remain suboptimal, and four out of 10 parents doubt the safety and efficacy of vaccines in France. The Ministry of Health therefore decided in July 2017 to expand vaccination requirements to 11 valences now required to enter in young children collective structures. This measure, which went into effect in January 2018, has produced significant effects on VCs, but despite this, vaccine hesitancy (VH) persists in the general population at a prevalence level that fluctuates around 20% to 25%.
Motivational interviewing is a collaborative conversational style that reinforces a person's own motivation and commitment to behavior change. It has been successfully tested in multiple domains related to health behavior change. It has also been adapted in Quebec in the area of vaccination and tested in maternity wards with postpartum mothers (Promovac study). Having led to an increase in the VCs of infants by an average of 7 percentage points and a 40% decrease in vaccine hesitancy, this approach has been in the process of being generalized to all maternity units in Quebec since 2017 (EMMIE program). It is indeed proving to be one of the most effective at present in improving confidence in early childhood vaccines.
Read more
OBJECTIVES The main objective of this research is to provide proof of concept that, in the French context of mandatory vaccination for infants but also of high rates of VH, an educational strategy based on the principles and techniques of motivational interviewing and carried out with parents in the maternity ward in the days following delivery can reduce vaccine hesitancy (VH).
The secondary objectives are as follows:
- to verify that this reduction in VH is associated with a change in knowledge, attitudes, and beliefs regarding vaccines;
- to verify that this reduction is sustainable (at 12 months);
- to evaluate the acceptability and satisfaction of the interview for the parents
METHODS This is a pragmatic randomized controlled multicenter study with individual randomization unit comparing the impact of motivational interviewing to a standard care with a leaflet on vaccination.
Motivational interviewing will be carried out by trained midwives from the two participating maternity units (one in Marseille (Bouches-du-Rhône) and the other in Toulon (Var)), as part of the routine care provided to parturients. The midwives will be trained by the founding specialist of motivational interviewing in Quebec, during a two and a half day training course. This training will include a presentation of the theoretical foundations of this approach, its adaptation to the field of vaccination, and interactive games to put it into practice. The trained midwives will then be able to put this approach into practice during a one-month pilot period with parturients, during which they will be able to benefit from support in the form of a debriefing. The actual survey will only start at the end of this pilot phase.
In each group, a questionnaire will be offered to the women (couples) who have agreed to participate, both before the motivational interview (or delivery of the leaflet) and after the interview (or delivery of the leaflet). The second questionnaire will be completed before discharge from the maternity hospital. A third evaluation time is planned at 12 months in both groups: it will be carried out by internet or telephone.
The primary endpoint will be the change in the vaccine hesitancy score, measured by an international scale validated in French (Opel scale).
Secondary endpoints will be changes in knowledge, attitudes and beliefs about vaccination between the two groups as well as satisfaction with the ME and the brochure.
Randomization will be performed in blocks of 8, prior to acceptance for participation in this research.
EXPECTED BENEFITS If the results of this research provide proof of concept that the educational strategy based on motivational interviewing adapted to the vaccination of infants after delivery, in maternity wards, makes it possible, in the French context, to reduce VH, this will be a major advance in public health in France. Indeed, even if the vaccination obligations introduced in January 2018 have had a positive impact on infant vaccination coverage, VH remains present in parents in a proportion that remains worrying (20 to 25% according to surveys). The results of this research will then allow us to study the conditions for generalizing motivational interviewing in order to reinforce confidence in vaccination, which is lacking in a significant part of the French population.
- Conditions
- Vaccination Promotion
- Being tested
- Motivational Interviewing, Information flyer
- Keywords
- Vaccine hesitancy, Motivational interviewing, Childhood vaccination
- Medical subject headings
- Vaccination Hesitancy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Motivational InterviewingBehavioural
Mothers randomized in the intervention group will receive an educational session based on the motivational interviewing (MI) approach with a midwife. The midwife will have first received a standardized 3 days training session on the content and techniques of MI. The MI intervention will be carried out in simple and understandable language in order to allow discussion and questions from parents rather than provide prescriptive and direct information. The intervention will last approximatively 15 to 20 minutes.
Information flyerOther
Mothers randomized in the control group will receive a locally information flyer on childhood vaccines without any oral explanation by the midwife.
| Study group | Role | What they receive |
|---|---|---|
| Motivational interviewing | Experimental | Educational session based on the motivational interviewing Receives: Behavioral: Motivational Interviewing |
| Information flyer | Other | Information flyer on childhood vaccines Receives: Other: Information flyer |
What is being measured
The primary outcome is the main question the study is designed to answer.
Vaccine hesitancy score (Opel score)
Parents' vaccine hesitancy score, regarding vaccination of their child, assessed by a questionnaire before and after the intervention at the maternity ward. Using the Opel score (Opel. Validity and reliability of a survey to identify vaccine-hesitant parents. Vaccine. 2011)
Measured: During the 72-hour postpartum stay at the maternity ward
Knowledge, attitudes, and beliefs regarding vaccines
Parents' knowledge, attitudes, and beliefs regarding vaccines, assessed by a questionnaire before and after the intervention at the maternity ward. Using the PromovaQ questionnaire, which was constructed and developed using a composite model inspired by the Health Belief Model and the Theory of Planned Behavior.
- Dubé. Overview of knowledge, attitudes, beliefs, vaccine hesitancy and vaccine acceptance among mothers of infants in Quebec, Canada. Human Vaccines \& Immunotherapeutics. 2018.
- Gagneur. Promoting vaccination in maternity wards - motivational interview technique reduces hesitancy and enhances intention to vaccinate, results from a multicentre non-controlled pre- and post-intervention RCT-nested study, Quebec, March 2014 to February 2015. Euro Surveillance. 2019.
- Gagneur. Promoting vaccination in the province of Québec, the PromoVaQ randomized controlled trial protocol. BMC Public Health. 2019.)
Measured: During the 72-hour postpartum stay at the maternity ward
Vaccine hesitancy score (Opel score) (sustainability)
Parents' vaccine hesitancy score, regarding vaccination of their child, assessed at 12 months by an online or by-phone questionnaire.
Measured: 12 months after the intervention at the maternity ward
Acceptability and satisfaction of the interview for the parents
Parents' acceptability and satisfaction of the interview assessed by a questionnaire after the intervention (MI or leaflet) at the maternity ward.
Measured: During the 72-hour postpartum stay at the maternity ward
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Oct 2021
- Study start8 Nov 2021
- Primary completion26 Apr 2022
- Study completion9 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Vaccination PromotionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 736 participants (actual)
Sponsor and investigators
- Lead sponsor
- Observatoire Regional de la Sante Provence-Alpes-Côte d'Azur
- Sponsor type
- University, hospital or other
- Collaborators
- CRES PACA Marseille, Institut de Recherche en Santé Publique, France, Hospital St. Joseph, Marseille, France, Hôpital Sainte-Musse CH Toulon, Université de Sherbrooke
- Responsible party
- Principal investigator, Pierre Verger, Observatoire Regional de la Sante Provence-Alpes-Côte d'Azur
- Investigators
- Pierre Verger, MD, Principal investigator, ORS PACA
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05093452
- Sponsor's protocol ID
- 2021-01-07-04
- Status last verified
- Nov 2023
- First submitted
- 24 Sep 2021
- Last updated
- 3 Nov 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Ramalli L, Cogordan C, Fressard L, Donato X, Biferi M, Verlomme V, Sonnier P, Meur H, Maradan G, Berenger C, Berthiaume P, Gagneur A, Verger P. Sustained impact of motivational interviewing on reducing vaccine hesitancy among postpartum mothers: A randomized control trial, Southeastern France, 2021 to 2022. Hum Vaccin Immunother. 2026 Dec;22(1):2611647. doi: 10.1080/21645515.2025.2611647. Epub 2026 Feb 2.
PubMed 41628064
Study at a glance
From the registry record, last updated by the sponsor on 3 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Motivational Interviewing of Parents in Maternity Wards About Vaccination (Entretien Motivationnel Sur la Vaccination auprès Des Parents Dans Les maternités)
- ClinicalTrials.gov ID
- NCT05093452
- Acronym / sponsor ID
- 2021-01-07-04
- Conditions
- Vaccination Promotion
- Keywords
- Vaccine hesitancy, Motivational interviewing, Childhood vaccination
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 736 participants (actual)
- Lead sponsor
- Observatoire Regional de la Sante Provence-Alpes-Côte d'AzurUniversity, hospital or other
- Collaborators
- CRES PACA Marseille, Institut de Recherche en Santé Publique, France, Hospital St. Joseph, Marseille, France, Hôpital Sainte-Musse CH Toulon, Université de Sherbrooke
- Study start
- 8 Nov 2021 (actual)
- Primary completion
- 26 Apr 2022 (actual)
- Study completion
- 9 Dec 2022 (actual)
- First posted
- 26 Oct 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
CONTEXT Vaccination has reduced mortality and morbidity by controlling many vaccine-preventable diseases. To prevent recurrence of these diseases, high vaccine coverages (VCs) (≥ 95%) are needed. But VCs for infants remain suboptimal, and four out of 10 parents doubt the safety and efficacy of vaccines in France. The Ministry of Health therefore decided in July 2017 to expand vaccination requirements to 11 valences now required to enter in young children collective structures. This measure, which went into effect in January 2018, has produced significant effects on VCs, but despite this, vaccine hesitancy (VH) persists in the general population at a prevalence level that fluctuates around 20% to 25%.
Motivational interviewing is a collaborative conversational style that reinforces a person's own motivation and commitment to behavior change. It has been successfully tested in multiple domains related to health behavior change. It has also been adapted in Quebec in the area of vaccination and tested in maternity wards with postpartum mothers (Promovac study). Having led to an increase in the VCs of infants by an average of 7 percentage points and a 40% decrease in vaccine hesitancy, this approach has been in the process of being generalized to all maternity units in Quebec since 2017 (EMMIE program). It is indeed proving to be one of the most effective at present in improving confidence in early childhood vaccines.
OBJECTIVES The main objective of this research is to provide proof of concept that, in the French context of mandatory vaccination for infants but also of high rates of VH, an educational strategy based on the principles and techniques of motivational interviewing and carried out with parents in the maternity ward in the days following delivery can reduce vaccine hesitancy (VH).
The secondary objectives are as follows:
- to verify that this reduction in VH is associated with a change in knowledge, attitudes, and beliefs regarding vaccines;
- to verify that this reduction is sustainable (at 12 months);
- to evaluate the acceptability and satisfaction of the interview for the parents
METHODS This is a pragmatic randomized controlled multicenter study with individual randomization unit comparing the impact of motivational interviewing to a standard care with a leaflet on vaccination.
Motivational interviewing will be carried out by trained midwives from the two participating maternity units (one in Marseille (Bouches-du-Rhône) and the other in Toulon (Var)), as part of the routine care provided to parturients. The midwives will be trained by the founding specialist of motivational interviewing in Quebec, during a two and a half day training course. This training will include a presentation of the theoretical foundations of this approach, its adaptation to the field of vaccination, and interactive games to put it into practice. The trained midwives will then be able to put this approach into practice during a one-month pilot period with parturients, during which they will be able to benefit from support in the form of a debriefing. The actual survey will only start at the end of this pilot phase.
In each group, a questionnaire will be offered to the women (couples) who have agreed to participate, both before the motivational interview (or delivery of the leaflet) and after the interview (or delivery of the leaflet). The second questionnaire will be completed before discharge from the maternity hospital. A third evaluation time is planned at 12 months in both groups: it will be carried out by internet or telephone.
The primary endpoint will be the change in the vaccine hesitancy score, measured by an international scale validated in French (Opel scale).
Secondary endpoints will be changes in knowledge, attitudes and beliefs about vaccination between the two groups as well as satisfaction with the ME and the brochure.
Randomization will be performed in blocks of 8, prior to acceptance for participation in this research.
EXPECTED BENEFITS If the results of this research provide proof of concept that the educational strategy based on motivational interviewing adapted to the vaccination of infants after delivery, in maternity wards, makes it possible, in the French context, to reduce VH, this will be a major advance in public health in France. Indeed, even if the vaccination obligations introduced in January 2018 have had a positive impact on infant vaccination coverage, VH remains present in parents in a proportion that remains worrying (20 to 25% according to surveys). The results of this research will then allow us to study the conditions for generalizing motivational interviewing in order to reinforce confidence in vaccination, which is lacking in a significant part of the French population.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Motivational interviewing | Experimental | Behavioral: Motivational InterviewingEducational session based on the motivational interviewing |
| Information flyer | Other | Other: Information flyerInformation flyer on childhood vaccines |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Mothers aged 18 years or more
- Mothers residing in the PACA region (Provence-Alpes-Côtes-d'Azur) at the time of the delivery
- Mothers who can read and speak French
- Mothers able to give a free and informed consent
- Mothers who provide written consent
Key exclusion criteria (2 listed)
- Mothers of new-born needing to be transferred in a 3rd level maternity ward (because of severe condition)
- Mothers who will leave early maternity ward (<24h)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Motivational InterviewingMothers randomized in the intervention group will receive an educational session based on the motivational interviewing (MI) approach with a midwife. The midwife will have first received a standardized 3 days training session on the content and techniques of MI. The MI intervention will be carried out in simple and understandable language in order to allow discussion and questions from parents rather than provide prescriptive and direct information. The intervention will last approximatively 15 to 20 minutes. | Behavioural | Motivational interviewing |
| Information flyerMothers randomized in the control group will receive a locally information flyer on childhood vaccines without any oral explanation by the midwife. | Other | Information flyer |
Primary outcome
Vaccine hesitancy score (Opel score)
Time frame: During the 72-hour postpartum stay at the maternity ward
Parents' vaccine hesitancy score, regarding vaccination of their child, assessed by a questionnaire before and after the intervention at the maternity ward. Using the Opel score (Opel. Validity and reliability of a survey to identify vaccine-hesitant parents. Vaccine. 2011)
Knowledge, attitudes, and beliefs regarding vaccines
Time frame: During the 72-hour postpartum stay at the maternity ward
Parents' knowledge, attitudes, and beliefs regarding vaccines, assessed by a questionnaire before and after the intervention at the maternity ward. Using the PromovaQ questionnaire, which was constructed and developed using a composite model inspired by the Health Belief Model and the Theory of Planned Behavior. * Dubé. Overview of knowledge, attitudes, beliefs, vaccine hesitancy and vaccine acceptance among mothers of infants in Quebec, Canada. Human Vaccines \& Immunotherapeutics. 2018. * Gagneur. Promoting vaccination in maternity wards - motivational interview technique reduces hesitancy and enhances intention to vaccinate, results from a multicentre non-controlled pre- and post-intervention RCT-nested study, Quebec, March 2014 to February 2015. Euro Surveillance. 2019. * Gagneur. Promoting vaccination in the province of Québec, the PromoVaQ randomized controlled trial protocol. BMC Public Health. 2019.)
Vaccine hesitancy score (Opel score) (sustainability)
Time frame: 12 months after the intervention at the maternity ward
Parents' vaccine hesitancy score, regarding vaccination of their child, assessed at 12 months by an online or by-phone questionnaire.
Acceptability and satisfaction of the interview for the parents
Time frame: During the 72-hour postpartum stay at the maternity ward
Parents' acceptability and satisfaction of the interview assessed by a questionnaire after the intervention (MI or leaflet) at the maternity ward.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Nov 2023.
- Derived from this study: PubMed 41628064Ramalli L, Cogordan C, Fressard L, Donato X, Biferi M, Verlomme V, Sonnier P, Meur H, Maradan G, Berenger C, Berthiaume P, Gagneur A, Verger P. Sustained impact of motivational interviewing on reducing vaccine hesitancy among postpartum mothers: A randomized control trial, Southeastern France, 2021 to 2022. Hum Vaccin Immunother. 2026 Dec;22(1):2611647. doi: 10.1080/21645515.2025.2611647. Epub 2026 Feb 2.
- Individual participant dataSharing planned: No
Related trials for Vaccination Promotion
Active, not recruitingPhase 3
PREVENT HPV -Related Cancers Trial
HPV Vaccination, Uptake Vaccination
Enrolling by invitation
Randomized Controlled Trial Of Text Messages To Increase Pneumococcal Vaccination In Adults In Chile.
Pneumococcal Infections, Immunization Programs
Active, not recruiting
OPERATION WIPE OUT: Multi-Channel Communication Campaign to Promote HPV Vaccination in Chambers County, Alabama
HPV Vaccination
Not yet recruiting
Development and Evaluation of a Digital Educational Intervention to Improve Vaccine Confidence and Communication Among Registered Nurses: Protocol for a Randomized Controlled Trial (VaxNurse-RCT).
Vaccine Hesitancy, Vaccine Acceptance
Recruiting
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
Human Papillomavirus-Related Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Pierre Verger, MD principal investigator
ORS PACA
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Motivational Interviewing and Information flyer in people with Vaccination Promotion, run by Observatoire Regional de la Sante Provence-Alpes-Côte d'Azur at 2 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Vaccine hesitancy score (Opel score) (time frame: During the 72-hour postpartum stay at the maternity ward). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05093452, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2023.